Dearborn Partners’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.6M Sell
106,920
-5,254
-5% -$650K 0.68% 55
2025
Q4
$14.1M Sell
112,174
-11,002
-9% -$1.44M 0.7% 55
2025
Q3
$18M Sell
123,176
-4,467
-3% -$675K 0.85% 46
2025
Q2
$19.9M Buy
127,643
+4,358
+4% +$691K 0.94% 44
2025
Q1
$20.3M Sell
123,285
-25,048
-17% -$4.17M 0.97% 43
2024
Q4
$24.2M Sell
148,333
-3,397
-2% -$608K 1.01% 45
2024
Q3
$29.6M Sell
151,730
-3,748
-2% -$691K 1.2% 41
2024
Q2
$27M Buy
155,478
+265
+0.2% +$44.1K 1.17% 40
2024
Q1
$26.3M Buy
155,213
+153,976
+12,448% +$28.8M 1.13% 44
2023
Q4
$244K Buy
1,237
+83
+7% +$14.7K 0.01% 232
2023
Q3
$201K Buy
+1,154
New +$210K 0.01% 233
2022
Q1
Sell
-991
Closed -$242K 287
2021
Q4
$242K Sell
991
-238
-19% -$52.1K 0.01% 244
2021
Q3
$239K Buy
1,229
+39
+3% +$7.87K 0.01% 224
2021
Q2
$222K Buy
+1,190
New +$207K 0.01% 236

Other funds holding ZTS

Dearborn Partners's ZTS Position: Q1 2026 in Review

Dearborn Partners reduced its Zoetis (ZTS) stake by 4.7% in Q1 2026, selling an estimated $650K and leaving 106,920 shares worth $12.6M. The position accounts for 0.68% of the portfolio, ranked #55.

Dearborn Partners first reported a position in ZTS in Q2 2021 and has held it in 14 quarters since. The position peaked at $29.6M in Q3 2024. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Dearborn Partners held 106,920 shares of Zoetis worth $12.6M as of Q1 2026.
  • Dearborn Partners sold 5,254 Zoetis shares in Q1 2026, an estimated $650K.
  • Zoetis made up 0.68% of Dearborn Partners's portfolio in Q1 2026, its #55 holding.
  • Dearborn Partners first reported a position in Zoetis in Q2 2021 and has held it in 14 quarters since.
  • Dearborn Partners's Zoetis position peaked at $29.6M in Q3 2024.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Dearborn Partners's 13F filing for Q1 2026, filed 12 May 2026.